Barclays’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $676M | Buy |
|
|||||
|
2025
Q1 | $628M | Buy |
|
|||||
|
2024
Q4 | $406M | Buy |
|
|||||
|
2024
Q3 | $355M | Sell |
|
|||||
|
2024
Q2 | $319M | Sell |
|
|||||
|
2024
Q1 | $499M | Buy |
|
|||||
|
2023
Q4 | $460M | Buy |
|
|||||
|
2023
Q3 | $286M | Sell |
|
|||||
|
2023
Q2 | $512M | Buy |
|
|||||
|
2023
Q1 | $375M | Sell |
|
|||||
|
2022
Q4 | $514M | Buy |
|
|||||
|
2022
Q3 | $114M | Sell |
|
|||||
|
2022
Q2 | $132M | Sell |
|
|||||
|
2022
Q1 | $174M | Sell |
|
|||||
|
2021
Q4 | $389M | Buy |
|
|||||
|
2021
Q3 | $216M | Buy |
|
|||||
|
2021
Q2 | $185M | Buy |
|
|||||
|
2021
Q1 | $171M | Buy |
|
|||||
|
2020
Q4 | $108M | Buy |
|
|||||
|
2020
Q3 | $90.9M | Buy |
|
|||||
|
2020
Q2 | $87.2M | Sell |
|
|||||
|
2020
Q1 | $181M | Sell |
|
|||||
|
2019
Q4 | $189M | Sell |
|
|||||
|
2019
Q3 | $244M | Buy |
|
|||||
|
2019
Q2 | $188M | Buy |
|
|||||
|
2019
Q1 | $170M | Buy |
|
|||||
|
2018
Q4 | $162M | Buy |
|
|||||
|
2018
Q3 | $168M | Sell |
|
|||||
|
2018
Q2 | $161M | Sell |
|
|||||
|
2018
Q1 | $222M | Buy |
|
|||||
|
2017
Q4 | $196M | Buy |
|
|||||
|
2017
Q3 | $164M | Sell |
|
|||||
|
2017
Q2 | $371M | Buy |
|
|||||
|
2017
Q1 | $303M | Buy |
|
|||||
|
2016
Q4 | $319M | Buy |
|
|||||
|
2016
Q3 | $274M | Buy |
|
|||||
|
2016
Q2 | $121M | Sell |
|
|||||
|
2016
Q1 | $385M | Buy |
|
|||||
|
2015
Q4 | $159M | Sell |
|
|||||
|
2015
Q3 | $217M | Sell |
|
|||||
|
2015
Q2 | $264M | Sell |
|
|||||
|
2015
Q1 | $277M | Sell |
|
|||||
|
2014
Q4 | $312M | Sell |
|
|||||
|
2014
Q3 | $378M | Buy |
|
|||||
|
2014
Q2 | $139M | Sell |
|
|||||
|
2014
Q1 | $331M | Buy |
|
|||||
|
2013
Q4 | $123M | Buy |
|
|||||
|
2013
Q3 | $86.6M | Buy |
|
|||||
|
2013
Q2 | $58.7M | Buy |
|